Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
Cancer Discovery|May 2, 2019
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating AgentsChen Lossos, Yunpeng Liu, Kellie E Kolb, et al.Blood|December 22, 2021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Wenchao Wu, Geoffrey M Nelson, Raphael Koch, et al.Nature Chemical Biology|October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.Nature|November 5, 2020
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.Nature Cancer|September 18, 2023
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphomaTim Wartewig, Jay Daniels, Miriam Schulz, et al.Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.Genes & Development|March 18, 2022
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemiaTaku Harada, Yaser Heshmati, Jérémie Kalfon, et al.The Journal of Experimental Medicine|January 25, 2012
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, Andrew A Lane, Liat Bird, et al.Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.Pageof 17